PICKERING GRANT
Insider CIK 1258693 · ATHA Director · PCVX President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-08 | 2026-09-09 | 17,056 | $60.36 | $1.03M | 429,902 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-08 | 2026-09-09 | 17,056 | $60.36 | $1.03M | 429,902 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-02 | 2026-09-02 | 3,427 | $61.58 | $211.0K | 446,958 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-02 | 2026-09-02 | 3,427 | $61.58 | $211.0K | 446,958 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-08-31 | 2026-09-02 | 2,862 | $60.74 | $173.8K | 450,385 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-08-31 | 2026-09-02 | 2,862 | $60.74 | $173.8K | 450,385 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-07-27 | 2026-07-28 | 16,198 | — | $0 | 137,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 378 | $55.91 | $21.1K | 133,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 11,783 | $55.52 | $654.2K | 457,662 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 4,415 | $55.93 | $246.9K | 453,247 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 756 | $55.52 | $42.0K | 133,459 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 244 | $55.96 | $13.7K | 133,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 622 | $55.54 | $34.5K | 133,593 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-07-27 | 2026-07-28 | 16,198 | $2.03 | $32.9K | 469,445 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-07-27 | 2026-07-28 | 16,198 | — | $0 | 137,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 378 | $55.91 | $21.1K | 133,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 622 | $55.54 | $34.5K | 133,593 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 244 | $55.96 | $13.7K | 133,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 756 | $55.52 | $42.0K | 133,459 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 4,415 | $55.93 | $246.9K | 453,247 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-27 | 2026-07-28 | 11,783 | $55.52 | $654.1K | 457,662 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-07-27 | 2026-07-28 | 16,198 | $2.03 | $32.9K | 469,445 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 332 | $55.99 | $18.6K | 134,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 356 | $55.23 | $19.7K | 134,547 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 312 | $54.35 | $17.0K | 134,903 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 6,417 | $56.12 | $360.1K | 452,466 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 9,137 | $55.27 | $505.0K | 458,883 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 6,683 | $54.28 | $362.8K | 468,020 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 191 | $56.27 | $10.7K | 134,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 602 | $55.30 | $33.3K | 134,406 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 207 | $54.22 | $11.2K | 135,008 | SEC↗ |
| LONA LeonaBio, Inc. | A Award deriv | 2026-06-23 | 2026-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-06-18 | 2026-06-18 | 225 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-18 | 2026-06-18 | 1,000 | $52.50 | $52.5K | 135,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-18 | 2026-06-18 | 1,000 | $52.50 | $52.5K | 135,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-18 | 2026-06-18 | 225 | $52.51 | $11.8K | 496,939 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-18 | 2026-06-18 | 22,236 | $52.50 | $1.17M | 474,703 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-06-18 | 2026-06-18 | 225 | $1.79 | $403 | 497,164 | SEC↗ |
| LONA LeonaBio, Inc. | A Award deriv | 2026-04-09 | 2026-04-13 | 28,000 | — | $0 | 28,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-03-09 | 2026-03-11 | 3,685 | $59.32 | $218.6K | 496,939 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-03-02 | 2026-03-02 | 2,531 | $61.98 | $156.9K | 500,624 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-02-28 | 2026-03-02 | 2,863 | $61.98 | $177.4K | 503,155 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 175,698 | — | $0 | 175,698 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2026-02-26 | 2026-03-02 | 105,110 | — | $0 | 506,018 | SEC↗ |
| PCVX Vaxcyte, Inc. | G Gift | 2026-01-14 | 2026-01-16 | 100,000 | — | $0 | 400,908 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-08 | 2025-09-10 | 7,356 | $32.41 | $238.4K | 500,908 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 2,857 | $31.56 | $90.2K | 516,247 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 3,420 | $31.56 | $107.9K | 508,264 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 4,563 | $31.56 | $144.0K | 511,684 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-05-30 | 2025-06-03 | 20,900 | — | $0 | 20,900 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-04-04 | 2025-04-07 | 15,781 | — | $0 | 186,936 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-04-04 | 2025-04-07 | 4,752 | — | $0 | 298,360 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-04-04 | 2025-04-07 | 4,752 | $20.93 | $99.5K | 518,775 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-04-04 | 2025-04-07 | 15,781 | $5.35 | $84.4K | 514,023 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-03-27 | 2025-03-03 | 57,938 | — | $0 | 508,239 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-03-03 | 2025-03-03 | 7,984 | $72.10 | $575.6K | 498,242 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-02-28 | 2025-03-03 | 2,013 | $73.02 | $147.0K | 506,226 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 193,431 | — | $0 | 193,431 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-09 | 2024-12-10 | 222 | $93.10 | $20.7K | 136,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-09 | 2024-12-10 | 154 | $93.60 | $14.4K | 136,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-09 | 2024-12-10 | 1,029 | $92.03 | $94.7K | 136,369 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-09 | 2024-12-10 | 961 | $92.06 | $88.5K | 136,437 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-02 | 2024-12-03 | 11,349 | $92.06 | $1.04M | 453,952 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-02 | 2024-12-03 | 2,242 | $94.06 | $210.9K | 450,301 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-02 | 2024-12-03 | 1,409 | $93.06 | $131.1K | 452,543 | SEC↗ |
| PCVX Vaxcyte, Inc. | G Gift | 2024-11-18 | 2024-11-19 | 710 | — | $0 | 465,301 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-11-07 | 2024-11-08 | 663 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-11-07 | 2024-11-08 | 14,129 | — | $0 | 153,198 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-11-07 | 2024-11-08 | 197,784 | — | $0 | 197,784 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-11-07 | 2024-11-08 | 80,625 | — | $0 | 80,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-11-07 | 2024-11-08 | 16,000 | — | $0 | 202,717 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-11-07 | 2024-11-08 | 16,000 | $5.35 | $85.6K | 466,011 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 105 | $105.50 | $11.1K | 137,398 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-11-07 | 2024-11-08 | 14,129 | $2.03 | $28.7K | 450,011 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-11-07 | 2024-11-08 | 663 | $0.04 | $27 | 435,882 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 463 | $103.43 | $47.9K | 137,891 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 377 | $104.71 | $39.5K | 137,514 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 116 | $105.50 | $12.2K | 137,398 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 281 | $102.64 | $28.8K | 138,300 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 363 | $103.36 | $37.5K | 137,937 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 434 | $104.72 | $45.4K | 137,503 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 227 | $102.68 | $23.3K | 138,354 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-01 | 2024-11-04 | 1,733 | $108.50 | $188.0K | 435,219 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-01 | 2024-11-04 | 3,312 | $107.34 | $355.5K | 436,952 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-01 | 2024-11-04 | 9,955 | $106.35 | $1.06M | 440,264 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 537 | $110.20 | $59.2K | 138,581 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 239 | $110.35 | $26.4K | 138,581 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 310 | $107.27 | $33.3K | 141,820 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 887 | $108.72 | $96.4K | 140,933 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 2,113 | $109.58 | $231.5K | 138,820 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 1,849 | $109.43 | $202.3K | 139,118 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 807 | $108.75 | $87.8K | 140,967 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 356 | $107.50 | $38.3K | 141,774 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-03 | 20,000 | — | $0 | 238,717 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-03 | 20,000 | — | $0 | 218,717 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 3,624 | $113.38 | $410.9K | 461,595 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 7,088 | $114.27 | $809.9K | 454,507 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 4,288 | $114.99 | $493.1K | 450,219 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-01 | 2024-10-03 | 20,000 | $5.35 | $107.0K | 470,219 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 9,429 | $114.20 | $1.08M | 456,485 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 6,266 | $114.93 | $720.2K | 450,219 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-01 | 2024-10-03 | 20,000 | $5.35 | $107.0K | 470,219 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 4,899 | $113.37 | $555.4K | 465,320 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 9,627 | $114.28 | $1.10M | 455,693 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 5,474 | $114.98 | $629.4K | 450,219 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 4,305 | $113.35 | $488.0K | 465,914 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-09-03 | 2024-09-05 | 13,669 | $110.15 | $1.51M | 465,219 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-08-23 | 2024-08-26 | 15,000 | — | $0 | 167,327 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-08-23 | 2024-08-26 | 15,000 | $2.03 | $30.4K | 493,888 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-23 | 2024-08-26 | 8,314 | $79.25 | $658.9K | 478,888 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-23 | 2024-08-26 | 6,686 | $78.65 | $525.9K | 487,202 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-01 | 2024-08-05 | 1,308 | $78.78 | $103.0K | 142,130 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-01 | 2024-08-05 | 1,308 | $78.80 | $103.1K | 142,130 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-07-23 | 2024-07-24 | 15,000 | — | $0 | 182,327 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-23 | 2024-07-24 | 5,718 | $83.83 | $479.3K | 488,170 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-07-23 | 2024-07-24 | 15,000 | $2.03 | $30.4K | 493,888 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-23 | 2024-07-24 | 9,282 | $84.53 | $784.6K | 478,888 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 674 | $75.84 | $51.1K | 144,072 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 557 | $76.89 | $42.8K | 143,438 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 751 | $75.92 | $57.0K | 143,995 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 634 | $76.86 | $48.7K | 143,438 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-06-24 | 2024-06-25 | 15,000 | — | $0 | 197,327 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-24 | 2024-06-25 | 188 | $76.80 | $14.4K | 478,888 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-24 | 2024-06-25 | 4,471 | $76.17 | $340.6K | 479,076 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-06-24 | 2024-06-25 | 15,000 | $2.03 | $30.4K | 493,888 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-24 | 2024-06-25 | 10,341 | $75.39 | $779.6K | 483,547 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 486 | $72.66 | $35.3K | 144,863 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 705 | $71.44 | $50.4K | 145,349 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 117 | $73.46 | $8.6K | 144,746 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 757 | $71.43 | $54.1K | 145,297 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 327 | $72.55 | $23.7K | 144,970 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 224 | $73.43 | $16.4K | 144,746 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-05-24 | 2024-05-24 | 20,900 | — | $0 | 20,900 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-05-23 | 2024-05-28 | 15,000 | — | $0 | 212,327 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-23 | 2024-05-28 | 6,211 | $68.84 | $427.6K | 486,636 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-23 | 2024-05-28 | 8,789 | $69.84 | $613.8K | 477,847 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-05-23 | 2024-05-28 | 15,000 | $2.03 | $30.4K | 492,847 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 728 | $61.25 | $44.6K | 146,634 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 508 | $62.01 | $31.5K | 146,126 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 72 | $63.87 | $4.6K | 146,054 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 680 | $61.28 | $41.7K | 146,682 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 582 | $62.07 | $36.1K | 146,100 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 46 | $63.84 | $2.9K | 146,054 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-04-23 | 2024-04-25 | 15,000 | — | $0 | 225 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-04-23 | 2024-04-25 | 15,000 | $1.79 | $26.9K | 492,847 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-23 | 2024-04-25 | 15,000 | $61.92 | $928.8K | 477,847 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 324 | $67.27 | $21.8K | 147,362 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 984 | $66.52 | $65.5K | 147,686 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 890 | $66.45 | $59.1K | 147,780 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 415 | $67.24 | $27.9K | 147,365 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 3 | $68.10 | $204 | 147,362 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-03-25 | 2024-03-27 | 15,000 | — | $0 | 15,225 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-25 | 2024-03-27 | 13,450 | $66.87 | $899.4K | 479,397 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-25 | 2024-03-27 | 1,550 | $67.50 | $104.6K | 477,847 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-03-25 | 2024-03-27 | 15,000 | $1.79 | $26.9K | 492,847 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-13 | 65,000 | — | $0 | 227,327 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-03-11 | 2024-03-13 | 65,000 | $2.03 | $131.9K | 477,847 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-03-02 | 2024-03-04 | 7,967 | $71.55 | $570.0K | 412,847 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 351 | $74.78 | $26.2K | 148,670 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 506 | $73.04 | $37.0K | 149,472 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 439 | $73.54 | $32.3K | 149,033 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 591 | $73.59 | $43.5K | 149,021 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 366 | $72.97 | $26.7K | 149,612 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 363 | $74.69 | $27.1K | 148,670 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 205,000 | — | $0 | 205,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2024-02-29 | 2024-03-04 | 45,000 | — | $0 | 420,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-02-26 | 2024-02-27 | 30,000 | — | $0 | 30,225 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-02-26 | 2024-02-27 | 30,000 | $1.79 | $53.7K | 405,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-26 | 2024-02-27 | 30,000 | $79.03 | $2.37M | 375,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-02-23 | 2024-02-27 | 15,000 | — | $0 | 60,225 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-23 | 2024-02-27 | 6,980 | $75.96 | $530.2K | 381,478 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-02-23 | 2024-02-27 | 15,000 | $1.79 | $26.9K | 390,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-23 | 2024-02-27 | 5,545 | $76.95 | $426.7K | 375,933 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-23 | 2024-02-27 | 119 | $77.56 | $9.2K | 375,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-23 | 2024-02-27 | 2,356 | $75.15 | $177.1K | 388,458 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 238 | $74.56 | $17.7K | 150,259 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 281 | $75.49 | $21.2K | 149,978 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 655 | $73.34 | $48.0K | 150,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 134 | $71.93 | $9.6K | 151,152 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 255 | $75.47 | $19.2K | 149,978 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 443 | $74.37 | $32.9K | 150,233 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 491 | $73.26 | $36.0K | 150,676 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 119 | $71.93 | $8.6K | 151,167 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-29 | 2024-01-31 | 30,000 | — | $0 | 75,225 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-29 | 2024-01-31 | 30,000 | $1.79 | $53.7K | 405,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-29 | 2024-01-31 | 30,000 | $66.03 | $1.98M | 375,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-23 | 2024-01-25 | 12,000 | — | $0 | 105,225 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-23 | 2024-01-25 | 3,000 | — | $0 | 663 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-23 | 2024-01-25 | 3,000 | $0.04 | $120 | 378,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-23 | 2024-01-25 | 12,000 | $1.79 | $21.5K | 390,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 10,023 | $63.95 | $641.0K | 377,853 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 2,039 | $64.78 | $132.1K | 375,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 2,938 | $63.22 | $185.7K | 387,876 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 594 | $63.65 | $37.8K | 151,873 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 587 | $64.33 | $37.8K | 151,286 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 97 | $62.91 | $6.1K | 152,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 568 | $63.68 | $36.2K | 151,929 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 643 | $64.24 | $41.3K | 151,286 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 127 | $62.93 | $8.0K | 152,467 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-12-26 | 2023-12-27 | 10,000 | — | $0 | 3,663 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-12-26 | 2023-12-27 | 10,000 | $0.04 | $400 | 390,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-26 | 2023-12-27 | 7,450 | $61.32 | $456.8K | 383,364 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-26 | 2023-12-27 | 7,550 | $62.08 | $468.7K | 375,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-12-22 | 2023-12-27 | 9,900 | — | $0 | 292,327 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-12-22 | 2023-12-27 | 9,900 | $2.03 | $20.1K | 380,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 841 | $52.50 | $44.2K | 152,594 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 552 | $52.68 | $29.1K | 152,594 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 468 | $51.43 | $24.1K | 153,435 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 757 | $51.71 | $39.1K | 153,146 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-24 | 2023-11-28 | 3,779 | $49.46 | $186.9K | 370,914 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-24 | 2023-11-28 | 11,221 | $48.96 | $549.4K | 374,693 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-01 | 2023-11-03 | 1,306 | $47.31 | $61.8K | 153,906 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-01 | 2023-11-03 | 3 | $48.10 | $144 | 153,903 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-01 | 2023-11-03 | 1,306 | $47.27 | $61.7K | 153,906 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-01 | 2023-11-03 | 3 | $48.10 | $144 | 153,903 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-23 | 2023-10-25 | 3,764 | $47.35 | $178.2K | 385,914 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-23 | 2023-10-25 | 11,236 | $46.98 | $527.9K | 389,678 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 641 | $49.67 | $31.8K | 155,880 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 283 | $51.52 | $14.6K | 155,212 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 646 | $49.68 | $32.1K | 155,875 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 221 | $50.48 | $11.2K | 155,654 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 442 | $51.55 | $22.8K | 155,212 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 385 | $50.76 | $19.5K | 155,495 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-09-25 | 2023-09-27 | 1,309 | $52.44 | $68.6K | 156,521 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-09-25 | 2023-09-27 | 1,309 | $52.42 | $68.6K | 156,521 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-09-25 | 2023-09-27 | 15,000 | $52.45 | $786.8K | 400,914 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-09-05 | 2023-09-06 | 10,378 | $51.00 | $529.3K | 415,914 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2023-05-19 | 2023-05-22 | 20,900 | — | $0 | 20,900 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-03-30 | 2023-03-31 | 15,000 | $2.47 | $37.0K | 25,783 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-03-29 | 2023-03-31 | 10,000 | $2.33 | $23.3K | 10,783 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-03-02 | 2023-03-03 | 3,099 | $41.49 | $128.6K | 425,252 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 323,250 | — | $0 | 323,250 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2023-03-01 | 2023-03-03 | 53,875 | — | $0 | 428,351 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-12-30 | 2023-01-04 | 15,158 | — | $0 | 302,227 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-12-30 | 2023-01-04 | 108,250 | — | $0 | 108,250 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-12-30 | 2023-01-04 | 15,158 | $2.03 | $30.8K | 374,476 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-26 | 2022-09-28 | 227 | $25.30 | $5.7K | 157,830 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-26 | 2022-09-28 | 4,773 | $24.69 | $117.8K | 158,057 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-26 | 2022-09-28 | 319 | $25.28 | $8.1K | 157,830 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-26 | 2022-09-28 | 4,681 | $24.68 | $115.5K | 158,149 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-15 | 2022-09-19 | 11,000 | $27.95 | $307.4K | 652,546 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2022-09-02 | 2022-09-07 | 8,910 | $26.38 | $235.0K | 663,546 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-26 | 2022-08-30 | 4,986 | $27.44 | $136.8K | 162,844 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-26 | 2022-08-30 | 14 | $28.00 | $392 | 162,830 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-26 | 2022-08-30 | 4,985 | $27.44 | $136.8K | 162,845 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-26 | 2022-08-30 | 15 | $28.00 | $420 | 162,830 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-15 | 2022-08-17 | 10,392 | $25.54 | $265.4K | 673,064 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-15 | 2022-08-17 | 608 | $26.30 | $16.0K | 672,456 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-07-26 | 2022-07-28 | 5,000 | $23.27 | $116.3K | 167,830 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-07-26 | 2022-07-28 | 5,000 | $23.26 | $116.3K | 167,830 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-07-15 | 2022-07-19 | 8,320 | $24.34 | $202.5K | 686,136 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-07-15 | 2022-07-19 | 2,680 | $24.88 | $66.7K | 683,456 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-06-28 | 2022-06-28 | 10,000 | $21.00 | $210.0K | 345,660 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-06-24 | 2022-06-28 | 747 | $21.01 | $15.7K | 694,456 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-06-23 | 2022-06-23 | 3,541 | $21.01 | $74.4K | 695,203 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-06-22 | 2022-06-23 | 1,261 | $21.01 | $26.5K | 698,744 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-06-21 | 2022-06-23 | 5,451 | $21.05 | $114.7K | 700,005 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2022-05-20 | 2022-05-27 | 3,467 | — | $0 | 3,467 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-05-16 | 2022-05-18 | 11,000 | — | $0 | 234,450 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-05-16 | 2022-05-18 | 3,134 | $24.28 | $76.1K | 703,894 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-05-16 | 2022-05-18 | 11,000 | $1.79 | $19.7K | 714,894 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-05-16 | 2022-05-18 | 7,866 | $23.76 | $186.9K | 707,028 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-04-18 | 2022-04-20 | 11,000 | — | $0 | 245,450 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-04-18 | 2022-04-20 | 11,000 | $23.98 | $263.8K | 703,894 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-04-18 | 2022-04-20 | 11,000 | $1.79 | $19.7K | 714,894 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-03-22 | 2022-03-23 | 7,712 | — | $0 | 256,450 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-03-22 | 2022-03-23 | 7,712 | $24.62 | $189.9K | 703,894 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-03-22 | 2022-03-23 | 7,712 | $1.79 | $13.8K | 711,606 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-03-21 | 2022-03-23 | 14,288 | — | $0 | 264,162 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-03-21 | 2022-03-23 | 359 | $25.68 | $9.2K | 703,894 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-03-21 | 2022-03-23 | 14,288 | $1.79 | $25.6K | 718,182 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-03-21 | 2022-03-23 | 13,929 | $24.92 | $347.1K | 704,253 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-03-02 | 2022-03-04 | 431,250 | — | $0 | 431,250 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2022-03-02 | 2022-03-04 | 71,875 | — | $0 | 703,894 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2022-01-27 | 2022-01-31 | 27,742 | — | $0 | 27,742 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-12-27 | 2021-12-28 | 50,365 | — | $0 | 278,450 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-12-27 | 2021-12-28 | 1,400 | — | $0 | 594,332 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-12-27 | 2021-12-28 | 50,365 | $1.79 | $90.2K | 630,619 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-12-27 | 2021-12-28 | 1,400 | $2.03 | $2.8K | 632,019 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-11-19 | 2021-11-23 | 15,000 | — | $0 | 328,815 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-11-19 | 2021-11-23 | 15,000 | $1.79 | $26.9K | 595,254 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-11-19 | 2021-11-23 | 5,890 | $24.00 | $141.4K | 580,254 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-11-19 | 2021-11-23 | 9,110 | $23.09 | $210.3K | 586,144 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-10-20 | 2021-10-22 | 15,000 | — | $0 | 343,815 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-10-20 | 2021-10-22 | 13,991 | $22.54 | $315.4K | 581,263 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-10-20 | 2021-10-22 | 1,009 | $23.19 | $23.4K | 580,254 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-10-20 | 2021-10-22 | 15,000 | $1.79 | $26.9K | 595,254 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-09-22 | 2021-09-23 | 4,193 | — | $0 | 358,815 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-09-22 | 2021-09-23 | 4,193 | $25.19 | $105.6K | 580,254 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-09-22 | 2021-09-23 | 4,193 | $1.79 | $7.5K | 584,447 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-09-21 | 2021-09-23 | 10,807 | — | $0 | 363,008 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-09-21 | 2021-09-23 | 802 | $25.89 | $20.8K | 580,254 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-09-21 | 2021-09-23 | 10,005 | $25.17 | $251.8K | 581,056 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-09-21 | 2021-09-23 | 10,807 | $1.79 | $19.3K | 591,061 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-08-23 | 2021-08-25 | 13,669 | — | $0 | 373,815 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-08-23 | 2021-08-25 | 13,600 | $22.73 | $309.1K | 580,323 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-08-23 | 2021-08-25 | 13,669 | $1.79 | $24.5K | 593,923 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-08-23 | 2021-08-25 | 69 | $23.10 | $1.6K | 580,254 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-08-19 | 2021-08-20 | 1,331 | — | $0 | 387,484 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-08-19 | 2021-08-20 | 1,331 | $1.79 | $2.4K | 581,585 | SEC↗ |